Page last updated: 2024-09-03

imatinib mesylate and Dermatitis, Eczematous

imatinib mesylate has been researched along with Dermatitis, Eczematous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huang, W; Li, J; Li, X; Qiu, F; Wu, X; Yao, G; Zhang, J; Zhu, S1
Ambrifi, M; Bottoni, U; Calvieri, S; Clerico, R; Corsetti, P; Didona, D; Paolino, G1

Other Studies

2 other study(ies) available for imatinib mesylate and Dermatitis, Eczematous

ArticleYear
Therapeutic drug monitoring-based dose optimization for imatinib-associated serious cutaneous reactions in a patient with gastrointestinal stromal tumours: A case report.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:4

    Topics: Aged; Drug Eruptions; Drug Monitoring; Eczema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Skin Diseases

2020
Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study.
    Cutis, 2016, Volume: 97, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dermatitis, Seborrheic; Dermatomycoses; Drug Eruptions; Eczema; Edema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histiocytoma, Benign Fibrous; Humans; Imatinib Mesylate; Keratosis, Actinic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Orbital Diseases; Prospective Studies; Pruritus; Psoriasis; Skin Neoplasms

2016